Affiliation:
1. Military Medical Academy named after S. M. Kirov
Abstract
The implementation of the target setting for the treatment of inflammatory bowel diseases — the achievement of clinical and endoscopic remission in each case, even taking into account biological therapy drugs, is not always achievable. It is obvious that patients with ulcerative colitis and Crohn’s disease are genetically heterogeneous in nature, which is manifested by the formation of various clinical and genetic phenotypes and various profiles of altered intestinal microbiota. Modern dietetics and nutritionology can be the most important fine-tuning tool in this chain of events and significantly increase the effectiveness of the therapy, equally contributing to both normalization of the intestinal microbial community and providing mechanisms for regulating gene expression (epigenetic effect).
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference31 articles.
1. Annese V., Lombardi G., Perri F. et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn’s disease – an IG-IBD study. Am. J. Gastroenterol. 2005, Vol.100, pp.84–92.
2. Annese V., Piepoli A., Latiano A. et al. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis. Colon Rectum, 2005, Vol.48, pp.57–65.
3. Brotherton C. S., Martin C. A., Long M. D. et al. Avoidance of fiber is associated with greater risk of Crohn’s disease flare in a 6-month period. Clin. Gastroenterol. Hepatol, 2016, Vol.14, pp.1130–6.
4. Calder P. C. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013;75(3):645–662.
5. Ferguson L. R. Nutrigenetics, Nutrigenomics and Inflammatory Bowel Diseases. Expert Rev. Clin. Immunol. 2013. Vol 9, pp.735–747.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献